(Q40774600)

23 September 2017

title

Ribozyme-mediated cleavage of wt1 transcripts suppresses growth of leukemia cells (English)

1 reference

23 September 2017

0 references

Hübinger G

1

1 reference

23 September 2017

Schmid M

2

1 reference

23 September 2017

Linortner S

3

1 reference

23 September 2017

Manegold A

4

1 reference

23 September 2017

Bergmann L

5

1 reference

23 September 2017

Maurer U

6

1 reference

23 September 2017

publication date

1 October 2001

1 reference

23 September 2017

published in

Experimental Hematology

1 reference

23 September 2017

volume

29

1 reference

23 September 2017

issue

10

1 reference

23 September 2017

page(s)

1226-1235

1 reference

Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus

23 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Alternative splicing and genomic structure of the Wilms tumor gene WT1

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Physical and functional interaction between WT1 and p53 proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

The Wilms' tumor gene product (WT1) modulates the response to 1,25-dihydroxyvitamin D3 by induction of the vitamin D receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

In vitro splicing of the ribosomal RNA precursor of tetrahymena: Involvement of a guanosine nucleotide in the excision of the intervening sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

A small catalytic oligoribonucleotide

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Ribozymes as human therapeutic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

The structure, function and application of the hammerhead ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Adenovirus-mediated expression of a ribozyme to c-myb mRNA inhibits smooth muscle cell proliferation and neointima formation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Chimeric DNA-RNA hammerhead ribozyme to proliferating cell nuclear antigen reduces stent-induced stenosis in a porcine coronary model

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Inhibition of cell proliferation in HCC-9204 hepatoma cells by a c-myc specific ribozyme.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Anti-K-ras ribozyme induces growth inhibition and increased chemosensitivity in human colon cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Adenovirus-mediated ribozyme targeting of HER-2/neu inhibits in vivo growth of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

A recombinant defective adenoviral agent expressing anti-bcl-2 ribozyme promotes apoptosis of bcl-2-expressing human prostate cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Adenovirus-encoded hammerhead ribozyme to Bcl-2 inhibits neointimal hyperplasia and induces vascular smooth muscle cell apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Tumor-specific expression of anti-mdr1 ribozyme selectively restores chemosensitivity in multidrug-resistant colon-adenocarcinoma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Retrovirally expressed anti-HIV ribozymes confer a selective survival advantage on CD4+ T cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Dose-response resistance to HIV-1/MuLV pseudotype virus ex vivo in a hairpin ribozyme transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

A phase I trial of autologous CD34+ hematopoietic progenitor cells transduced with an anti-HIV ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

A multifunctional expression vector for an anti-HIV-1 ribozyme that produces a 5'- and 3'-trimmed trans-acting ribozyme, targeted against HIV-1 RNA, and cis-acting ribozymes that are designed to bind to and thereby sequester trans-activator proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

The tyrosine kinase NPM-ALK, associated with anaplastic large cell lymphoma, binds the intracellular domain of the surface receptor CD30 but is not activated by CD30 stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Induction of Rb-associated protein (RbAp46) by Wilms' tumor suppressor WT1 mediates growth inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Enzymatic and antisense effects of a specific anti-Ki-ras ribozyme in vitro and in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Searching for the ideal partner

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

Selection of efficient cleavage sites in target RNAs by using a ribozyme expression library

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2801%2900719-6

7 January 2021

10.1016/S0301-472X(01)00719-6

Identifiers

DOI

1 reference

23 September 2017

1 reference